HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Hepion Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.10−0.00 (-1.45%)
Close on Oct 19, 2026
- Market cap
- $1.65M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.0311 (+43.80%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $1.65M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.29
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$3.19M
- EPS, diluted
- -$0.88
- Book value per share
- $0.08
- Diluted shares
- 16M
Twelve years at a glance
Fiscal years 2013 to 2025 and trailing twelve months, USD
Revenue
–
Operating income
-$3.15M
Net income
-$3.19M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months